A pavilion showcasing Swiss innovative companies with Personalised
Medicine solutions at NHS Innovation & Care Expo 2017

Swiss Pavilion - Manchestert - 11 & 12September 2017



NHS Innovation & Care Expo is the only exhibition where all the levels of the NHS are present and eager to hear about new models of care. All the directors of the initiatives designed by the board of the NHS to accelerate the adoption of innovation are represented, NHS commissioners, CEOs of hospitals and NHS trusts, as well as senior practitioners and opinion leaders. It is a unique opportunity to engage with UK decision makers and either initiate direct sales or trigger pilot programs with the diverse entities of NHS England.


The Swiss pavilion will consist in approx. 45 m2 where 6 to 8 Swiss com panies will be invited to showcase their Personalised Medicine solutions. In addition to this, a specific Swiss program resonating with the NHS England preoccupations will be designed to guarantee continuous traffic for the Swiss exhibitors. Relevant topics will include: personalized medicine, digitization techno logies, remote health monitoring and care, process optimization. A targeted communication campaign, notably on the social media, will be run to raise awareness and build-up the NHS executives interest prior to the event and to facilitate the follow-up after the event.


Speaking opportunities are available on the Swiss pavilion.


Contact us for more details



Find an actor

Journée de l'Innovation 2017 aux HUG Jeudi 19 octobre19.10.2017

11ème Journée de l’innovation au Centre de l’innovation des HUG. Conférences, concours de pitchs, remise des...

Pryv SA closes 1.1M CHF Pre-Series A to accelerate growth and prepare Series A funding round

Pryv SA, an independent Swiss Health-IT company, specialized in providing innovative data management and digital...
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn